Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The systemic renin-angiotensin system in COVID-19.
Reindl-Schwaighofer R, Hödlmoser S, Domenig O, Krenn K, Eskandary F, Krenn S, Schörgenhofer C, Rumpf B, Karolyi M, Traugott MT, Abrahamowicz A, Tinhof V, Mayfurth H, Rathkolb V, Mußnig S, Schmölz L, Ullrich R, Heinzel A, König F, Binder C, Bonderman D, Strassl R, Puchhammer-Stöckl E, Gorkiewicz G, Aberle JH, Jilma B, Wenisch C, Poglitsch M, Oberbauer R, Zoufaly A, Hecking M. Reindl-Schwaighofer R, et al. Among authors: jilma b. Sci Rep. 2022 Nov 22;12(1):20117. doi: 10.1038/s41598-022-24628-1. Sci Rep. 2022. PMID: 36418458 Free PMC article.
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers.
Pirabe A, Schrottmaier WC, Heber S, Schmuckenschlager A, Treiber S, Pereyra D, Santol J, Pawelka E, Traugott M, Schörgenhofer C, Seitz T, Karolyi M, Jilma B, Resch U, Zoufaly A, Assinger A. Pirabe A, et al. Among authors: jilma b. J Infect Public Health. 2023 Mar;16(3):384-392. doi: 10.1016/j.jiph.2023.01.016. Epub 2023 Jan 21. J Infect Public Health. 2023. PMID: 36702013 Free PMC article.
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial.
Rathkolb V, Traugott MT, Heinzel A, Poglitsch M, Aberle J, Eskandary F, Abrahamowicz A, Mueller M, Knollmueller P, Shoumariyeh T, Stuflesser J, Seeber I, Gibas G, Mayfurth H, Tinhof V, Schmoelz L, Zeitlinger M, Schoergenhofer C, Jilma B, Genser B, Hoepler W, Omid S, Karolyi M, Wenisch C, Oberbauer R, Zoufaly A, Hecking M, Reindl-Schwaighofer R. Rathkolb V, et al. Among authors: jilma b. iScience. 2023 Oct 5;26(11):108146. doi: 10.1016/j.isci.2023.108146. eCollection 2023 Nov 17. iScience. 2023. PMID: 37867935 Free PMC article.
Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome.
Bischof T, Schaller C, Buchtele N, Staudinger T, Ullrich R, Kraft F, Andersson ML, Jilma B, Schoergenhofer C. Bischof T, et al. Among authors: jilma b. Pharmaceutics. 2024 Feb 21;16(3):303. doi: 10.3390/pharmaceutics16030303. Pharmaceutics. 2024. PMID: 38543197 Free PMC article.
Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalized adults with COVID-19: a population-based, retrospective cohort study.
Jorda A, Ensle D, Eser H, Glötzl F, Riedl B, Szell M, Valipour A, Zoufaly A, Wenisch C, Haider D, Burgmann H, Thalhammer F, Götzinger F, Jilma B, Ristl R, Karnthaler U, Zeitlinger M. Jorda A, et al. Among authors: jilma b. Clin Microbiol Infect. 2024 Nov 4:S1198-743X(24)00508-1. doi: 10.1016/j.cmi.2024.10.026. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39505067 Free article.
The dynamics of thrombolysis over time in acute immunologic reactions.
Kienbacher CL, Schörgenhofer C, Ruzicka G, Grafeneder J, Hufnagl C, Jilma B, Schwameis M, Herkner H. Kienbacher CL, et al. Among authors: jilma b. Sci Rep. 2025 Jan 2;15(1):123. doi: 10.1038/s41598-024-84070-3. Sci Rep. 2025. PMID: 39747939 Free PMC article.
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10.
Mayer KA, Doberer K, Halloran PF, Budde K, Haindl S, Mühlbacher J, Eskandary F, Viard T, Casas S, Jilma B, Böhmig GA. Mayer KA, et al. Among authors: jilma b. Transplant Direct. 2022 Nov 10;8(12):e1406. doi: 10.1097/TXD.0000000000001406. eCollection 2022 Dec. Transplant Direct. 2022. PMID: 36382130 Free PMC article.
A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
Haupenthal F, Rahn J, Maggi F, Gelas F, Bourgeois P, Hugo C, Jilma B, Böhmig GA, Herkner H, Wolzt M, Doberer K, Vossen M, Focosi D, Neuwirt H, Banas M, Banas B, Budde K, Viklicky O, Malvezzi P, Rostaing L, Rotmans JI, Bakker SJL, Eller K, Cejka D, Pérez AM, Rodriguez-Arias D, König F, Bond G; TTVguideTX consortium partners. Haupenthal F, et al. Among authors: jilma b. Trials. 2023 Mar 22;24(1):213. doi: 10.1186/s13063-023-07216-0. Trials. 2023. PMID: 36949445 Free PMC article. Clinical Trial.
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: jilma b. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.
577 results